InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.58
(
0.03%
)
US TECH 100
18,960.40
(
0.16%
)
Dow Jones
41,606.18
(
-0.04%
)
Brent Oil
72.77
(
-0.76%
)
Bitcoin
60,358.18
(
0.10%
)
Post# of 253142
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120456
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 54629

Saturday, 11/17/2007 6:27:02 PM

Saturday, November 17, 2007 6:27:02 PM

Post# of 253142
>MNTA – That would explain no request for this data from Teva or Amphastar.<

Amphastar got the same FDA letter about immunogenicity concerns that Sandoz/MNTA got, according to WPI’s CEO on the Credit Suisse webcast two days ago. He said Teva got the same letter too, although he didn’t disclose how he knows that. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up